Q4 2018 13F Holders as of 31 Dec 2018
-
Type / Class
-
Equity / Ordinary Shares, par value $0.0001 per share
-
Shares outstanding
-
134M
-
Number of holders
-
36
-
Total 13F shares, excl. options
-
7.52M
-
Shares change
-
-4.27K
-
Total reported value, excl. options
-
$48.5M
-
Value change
-
-$227K
-
Put/Call ratio
-
0.69
-
Number of buys
-
12
-
Number of sells
-
-22
-
Price
-
$6.45
Significant Holders of Global Cord Blood Corp - Ordinary Shares, par value $0.0001 per share (CORBF) as of Q4 2018
52 filings reported holding CORBF - Global Cord Blood Corp - Ordinary Shares, par value $0.0001 per share as of Q4 2018.
Global Cord Blood Corp - Ordinary Shares, par value $0.0001 per share (CORBF) has 36 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 7.52M shares
of 134M outstanding shares and own 5.62% of the company stock.
Largest 10 shareholders include RENAISSANCE TECHNOLOGIES LLC (2.59M shares), Vanguard Group Inc (1.19M shares), Rock Springs Capital Management LP (925K shares), Man Group plc (708K shares), NORGES BANK (644K shares), UBS Group AG (346K shares), Quinn Opportunity Partners LLC (254K shares), PEAK6 Investments LLC (104K shares), CITADEL ADVISORS LLC (103K shares), and BANK OF AMERICA CORP /DE/ (87K shares).
This table shows the top 36 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.